0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Universal Cell Therapy Drug Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-14U15769
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Universal Cell Therapy Drug Market Research Report 2023
BUY CHAPTERS

Global Universal Cell Therapy Drug Market Research Report 2024

Code: QYRE-Auto-14U15769
Report
August 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Universal Cell Therapy Drug Market Size

The global Universal Cell Therapy Drug market was valued at US$ 359 million in 2023 and is anticipated to reach US$ 1063.8 million by 2030, witnessing a CAGR of 16.8% during the forecast period 2024-2030.

Universal Cell Therapy Drug Market

Universal Cell Therapy Drug Market

Universal cell therapies are a revolutionary class of medicines that use biotechnology to modify a patient's cells to treat a variety of diseases, including cancer, genetic disorders and autoimmune diseases. Increasingly, generic cell therapies will move toward personalized treatments to tailor treatment plans to each patient's specific condition and genotype. Universal cell therapies continue to expand their indications to include the treatment of rare diseases, autoimmune diseases and other diseases. Universal cell therapy drugs represent an important innovation in medicine, providing new treatment options for patients with serious diseases. With the continuous development of technology and the accumulation of clinical practice, universal cell therapy will continue to play an important role in the medical field.
This report aims to provide a comprehensive presentation of the global market for Universal Cell Therapy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Universal Cell Therapy Drug.

Report Scope

The Universal Cell Therapy Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Universal Cell Therapy Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Universal Cell Therapy Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Universal Cell Therapy Drug Market Report

Report Metric Details
Report Name Universal Cell Therapy Drug Market
Accounted market size in 2023 US$ 359 million
Forecasted market size in 2030 US$ 1063.8 million
CAGR 16.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Cell Therapy
  • Gene Therapy
  • Stem Cell Therapy
Segment by Application
  • Hospital
  • Research Center
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Gilead Sciences, Bluebird Bio, Juno Therapeutics, Spark Therapeutics, Kite Pharma, Celgene, Regeneron Pharmaceuticals, Adaptimmune, CRISPR Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Universal Cell Therapy Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Universal Cell Therapy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Universal Cell Therapy Drug Market growing?

Ans: The Universal Cell Therapy Drug Market witnessing a CAGR of 16.8% during the forecast period 2024-2030.

What is the Universal Cell Therapy Drug Market size in 2030?

Ans: The Universal Cell Therapy Drug Market size in 2030 will be US$ 1063.8 million.

Who are the main players in the Universal Cell Therapy Drug Market report?

Ans: The main players in the Universal Cell Therapy Drug Market are Novartis, Gilead Sciences, Bluebird Bio, Juno Therapeutics, Spark Therapeutics, Kite Pharma, Celgene, Regeneron Pharmaceuticals, Adaptimmune, CRISPR Therapeutics

What are the Application segmentation covered in the Universal Cell Therapy Drug Market report?

Ans: The Applications covered in the Universal Cell Therapy Drug Market report are Hospital, Research Center

What are the Type segmentation covered in the Universal Cell Therapy Drug Market report?

Ans: The Types covered in the Universal Cell Therapy Drug Market report are Cell Therapy, Gene Therapy, Stem Cell Therapy

1 Universal Cell Therapy Drug Market Overview
1.1 Product Overview and Scope of Universal Cell Therapy Drug
1.2 Universal Cell Therapy Drug Segment by Type
1.2.1 Global Universal Cell Therapy Drug Market Value Comparison by Type (2024-2030)
1.2.2 Cell Therapy
1.2.3 Gene Therapy
1.2.4 Stem Cell Therapy
1.3 Universal Cell Therapy Drug Segment by Application
1.3.1 Global Universal Cell Therapy Drug Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Research Center
1.4 Global Universal Cell Therapy Drug Market Size Estimates and Forecasts
1.4.1 Global Universal Cell Therapy Drug Revenue 2019-2030
1.4.2 Global Universal Cell Therapy Drug Sales 2019-2030
1.4.3 Global Universal Cell Therapy Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Universal Cell Therapy Drug Market Competition by Manufacturers
2.1 Global Universal Cell Therapy Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Universal Cell Therapy Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Universal Cell Therapy Drug Average Price by Manufacturers (2019-2024)
2.4 Global Universal Cell Therapy Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Universal Cell Therapy Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Universal Cell Therapy Drug, Product Type & Application
2.7 Universal Cell Therapy Drug Market Competitive Situation and Trends
2.7.1 Universal Cell Therapy Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Universal Cell Therapy Drug Players Market Share by Revenue
2.7.3 Global Universal Cell Therapy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Universal Cell Therapy Drug Retrospective Market Scenario by Region
3.1 Global Universal Cell Therapy Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Universal Cell Therapy Drug Global Universal Cell Therapy Drug Sales by Region: 2019-2030
3.2.1 Global Universal Cell Therapy Drug Sales by Region: 2019-2024
3.2.2 Global Universal Cell Therapy Drug Sales by Region: 2025-2030
3.3 Global Universal Cell Therapy Drug Global Universal Cell Therapy Drug Revenue by Region: 2019-2030
3.3.1 Global Universal Cell Therapy Drug Revenue by Region: 2019-2024
3.3.2 Global Universal Cell Therapy Drug Revenue by Region: 2025-2030
3.4 North America Universal Cell Therapy Drug Market Facts & Figures by Country
3.4.1 North America Universal Cell Therapy Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Universal Cell Therapy Drug Sales by Country (2019-2030)
3.4.3 North America Universal Cell Therapy Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Universal Cell Therapy Drug Market Facts & Figures by Country
3.5.1 Europe Universal Cell Therapy Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Universal Cell Therapy Drug Sales by Country (2019-2030)
3.5.3 Europe Universal Cell Therapy Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Universal Cell Therapy Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Universal Cell Therapy Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Universal Cell Therapy Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Universal Cell Therapy Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Universal Cell Therapy Drug Market Facts & Figures by Country
3.7.1 Latin America Universal Cell Therapy Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Universal Cell Therapy Drug Sales by Country (2019-2030)
3.7.3 Latin America Universal Cell Therapy Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Universal Cell Therapy Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Universal Cell Therapy Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Universal Cell Therapy Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Universal Cell Therapy Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Universal Cell Therapy Drug Sales by Type (2019-2030)
4.1.1 Global Universal Cell Therapy Drug Sales by Type (2019-2024)
4.1.2 Global Universal Cell Therapy Drug Sales by Type (2025-2030)
4.1.3 Global Universal Cell Therapy Drug Sales Market Share by Type (2019-2030)
4.2 Global Universal Cell Therapy Drug Revenue by Type (2019-2030)
4.2.1 Global Universal Cell Therapy Drug Revenue by Type (2019-2024)
4.2.2 Global Universal Cell Therapy Drug Revenue by Type (2025-2030)
4.2.3 Global Universal Cell Therapy Drug Revenue Market Share by Type (2019-2030)
4.3 Global Universal Cell Therapy Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Universal Cell Therapy Drug Sales by Application (2019-2030)
5.1.1 Global Universal Cell Therapy Drug Sales by Application (2019-2024)
5.1.2 Global Universal Cell Therapy Drug Sales by Application (2025-2030)
5.1.3 Global Universal Cell Therapy Drug Sales Market Share by Application (2019-2030)
5.2 Global Universal Cell Therapy Drug Revenue by Application (2019-2030)
5.2.1 Global Universal Cell Therapy Drug Revenue by Application (2019-2024)
5.2.2 Global Universal Cell Therapy Drug Revenue by Application (2025-2030)
5.2.3 Global Universal Cell Therapy Drug Revenue Market Share by Application (2019-2030)
5.3 Global Universal Cell Therapy Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Universal Cell Therapy Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Universal Cell Therapy Drug Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Corporation Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences Universal Cell Therapy Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Gilead Sciences Universal Cell Therapy Drug Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 Bluebird Bio
6.3.1 Bluebird Bio Corporation Information
6.3.2 Bluebird Bio Description and Business Overview
6.3.3 Bluebird Bio Universal Cell Therapy Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bluebird Bio Universal Cell Therapy Drug Product Portfolio
6.3.5 Bluebird Bio Recent Developments/Updates
6.4 Juno Therapeutics
6.4.1 Juno Therapeutics Corporation Information
6.4.2 Juno Therapeutics Description and Business Overview
6.4.3 Juno Therapeutics Universal Cell Therapy Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Juno Therapeutics Universal Cell Therapy Drug Product Portfolio
6.4.5 Juno Therapeutics Recent Developments/Updates
6.5 Spark Therapeutics
6.5.1 Spark Therapeutics Corporation Information
6.5.2 Spark Therapeutics Description and Business Overview
6.5.3 Spark Therapeutics Universal Cell Therapy Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Spark Therapeutics Universal Cell Therapy Drug Product Portfolio
6.5.5 Spark Therapeutics Recent Developments/Updates
6.6 Kite Pharma
6.6.1 Kite Pharma Corporation Information
6.6.2 Kite Pharma Description and Business Overview
6.6.3 Kite Pharma Universal Cell Therapy Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kite Pharma Universal Cell Therapy Drug Product Portfolio
6.6.5 Kite Pharma Recent Developments/Updates
6.7 Celgene
6.6.1 Celgene Corporation Information
6.6.2 Celgene Description and Business Overview
6.6.3 Celgene Universal Cell Therapy Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Celgene Universal Cell Therapy Drug Product Portfolio
6.7.5 Celgene Recent Developments/Updates
6.8 Regeneron Pharmaceuticals
6.8.1 Regeneron Pharmaceuticals Corporation Information
6.8.2 Regeneron Pharmaceuticals Description and Business Overview
6.8.3 Regeneron Pharmaceuticals Universal Cell Therapy Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Regeneron Pharmaceuticals Universal Cell Therapy Drug Product Portfolio
6.8.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.9 Adaptimmune
6.9.1 Adaptimmune Corporation Information
6.9.2 Adaptimmune Description and Business Overview
6.9.3 Adaptimmune Universal Cell Therapy Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Adaptimmune Universal Cell Therapy Drug Product Portfolio
6.9.5 Adaptimmune Recent Developments/Updates
6.10 CRISPR Therapeutics
6.10.1 CRISPR Therapeutics Corporation Information
6.10.2 CRISPR Therapeutics Description and Business Overview
6.10.3 CRISPR Therapeutics Universal Cell Therapy Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CRISPR Therapeutics Universal Cell Therapy Drug Product Portfolio
6.10.5 CRISPR Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Universal Cell Therapy Drug Industry Chain Analysis
7.2 Universal Cell Therapy Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Universal Cell Therapy Drug Production Mode & Process
7.4 Universal Cell Therapy Drug Sales and Marketing
7.4.1 Universal Cell Therapy Drug Sales Channels
7.4.2 Universal Cell Therapy Drug Distributors
7.5 Universal Cell Therapy Drug Customers
8 Universal Cell Therapy Drug Market Dynamics
8.1 Universal Cell Therapy Drug Industry Trends
8.2 Universal Cell Therapy Drug Market Drivers
8.3 Universal Cell Therapy Drug Market Challenges
8.4 Universal Cell Therapy Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Universal Cell Therapy Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Universal Cell Therapy Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Universal Cell Therapy Drug Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Universal Cell Therapy Drug Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Universal Cell Therapy Drug Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Universal Cell Therapy Drug Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Universal Cell Therapy Drug Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Universal Cell Therapy Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Universal Cell Therapy Drug, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Universal Cell Therapy Drug, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Universal Cell Therapy Drug, Product Type & Application
    Table 12. Global Key Manufacturers of Universal Cell Therapy Drug, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Universal Cell Therapy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Universal Cell Therapy Drug as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Universal Cell Therapy Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Universal Cell Therapy Drug Sales by Region (2019-2024) & (K Units)
    Table 18. Global Universal Cell Therapy Drug Sales Market Share by Region (2019-2024)
    Table 19. Global Universal Cell Therapy Drug Sales by Region (2025-2030) & (K Units)
    Table 20. Global Universal Cell Therapy Drug Sales Market Share by Region (2025-2030)
    Table 21. Global Universal Cell Therapy Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Universal Cell Therapy Drug Revenue Market Share by Region (2019-2024)
    Table 23. Global Universal Cell Therapy Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Universal Cell Therapy Drug Revenue Market Share by Region (2025-2030)
    Table 25. North America Universal Cell Therapy Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Universal Cell Therapy Drug Sales by Country (2019-2024) & (K Units)
    Table 27. North America Universal Cell Therapy Drug Sales by Country (2025-2030) & (K Units)
    Table 28. North America Universal Cell Therapy Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Universal Cell Therapy Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Universal Cell Therapy Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Universal Cell Therapy Drug Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Universal Cell Therapy Drug Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Universal Cell Therapy Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Universal Cell Therapy Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Universal Cell Therapy Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Universal Cell Therapy Drug Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Universal Cell Therapy Drug Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Universal Cell Therapy Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Universal Cell Therapy Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Universal Cell Therapy Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Universal Cell Therapy Drug Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Universal Cell Therapy Drug Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Universal Cell Therapy Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Universal Cell Therapy Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Universal Cell Therapy Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Universal Cell Therapy Drug Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Universal Cell Therapy Drug Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Universal Cell Therapy Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Universal Cell Therapy Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Universal Cell Therapy Drug Sales (K Units) by Type (2019-2024)
    Table 51. Global Universal Cell Therapy Drug Sales (K Units) by Type (2025-2030)
    Table 52. Global Universal Cell Therapy Drug Sales Market Share by Type (2019-2024)
    Table 53. Global Universal Cell Therapy Drug Sales Market Share by Type (2025-2030)
    Table 54. Global Universal Cell Therapy Drug Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Universal Cell Therapy Drug Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Universal Cell Therapy Drug Revenue Market Share by Type (2019-2024)
    Table 57. Global Universal Cell Therapy Drug Revenue Market Share by Type (2025-2030)
    Table 58. Global Universal Cell Therapy Drug Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Universal Cell Therapy Drug Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Universal Cell Therapy Drug Sales (K Units) by Application (2019-2024)
    Table 61. Global Universal Cell Therapy Drug Sales (K Units) by Application (2025-2030)
    Table 62. Global Universal Cell Therapy Drug Sales Market Share by Application (2019-2024)
    Table 63. Global Universal Cell Therapy Drug Sales Market Share by Application (2025-2030)
    Table 64. Global Universal Cell Therapy Drug Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Universal Cell Therapy Drug Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Universal Cell Therapy Drug Revenue Market Share by Application (2019-2024)
    Table 67. Global Universal Cell Therapy Drug Revenue Market Share by Application (2025-2030)
    Table 68. Global Universal Cell Therapy Drug Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Universal Cell Therapy Drug Price (US$/Unit) by Application (2025-2030)
    Table 70. Novartis Corporation Information
    Table 71. Novartis Description and Business Overview
    Table 72. Novartis Universal Cell Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Novartis Universal Cell Therapy Drug Product
    Table 74. Novartis Recent Developments/Updates
    Table 75. Gilead Sciences Corporation Information
    Table 76. Gilead Sciences Description and Business Overview
    Table 77. Gilead Sciences Universal Cell Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Gilead Sciences Universal Cell Therapy Drug Product
    Table 79. Gilead Sciences Recent Developments/Updates
    Table 80. Bluebird Bio Corporation Information
    Table 81. Bluebird Bio Description and Business Overview
    Table 82. Bluebird Bio Universal Cell Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Bluebird Bio Universal Cell Therapy Drug Product
    Table 84. Bluebird Bio Recent Developments/Updates
    Table 85. Juno Therapeutics Corporation Information
    Table 86. Juno Therapeutics Description and Business Overview
    Table 87. Juno Therapeutics Universal Cell Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Juno Therapeutics Universal Cell Therapy Drug Product
    Table 89. Juno Therapeutics Recent Developments/Updates
    Table 90. Spark Therapeutics Corporation Information
    Table 91. Spark Therapeutics Description and Business Overview
    Table 92. Spark Therapeutics Universal Cell Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Spark Therapeutics Universal Cell Therapy Drug Product
    Table 94. Spark Therapeutics Recent Developments/Updates
    Table 95. Kite Pharma Corporation Information
    Table 96. Kite Pharma Description and Business Overview
    Table 97. Kite Pharma Universal Cell Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Kite Pharma Universal Cell Therapy Drug Product
    Table 99. Kite Pharma Recent Developments/Updates
    Table 100. Celgene Corporation Information
    Table 101. Celgene Description and Business Overview
    Table 102. Celgene Universal Cell Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Celgene Universal Cell Therapy Drug Product
    Table 104. Celgene Recent Developments/Updates
    Table 105. Regeneron Pharmaceuticals Corporation Information
    Table 106. Regeneron Pharmaceuticals Description and Business Overview
    Table 107. Regeneron Pharmaceuticals Universal Cell Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Regeneron Pharmaceuticals Universal Cell Therapy Drug Product
    Table 109. Regeneron Pharmaceuticals Recent Developments/Updates
    Table 110. Adaptimmune Corporation Information
    Table 111. Adaptimmune Description and Business Overview
    Table 112. Adaptimmune Universal Cell Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Adaptimmune Universal Cell Therapy Drug Product
    Table 114. Adaptimmune Recent Developments/Updates
    Table 115. CRISPR Therapeutics Corporation Information
    Table 116. CRISPR Therapeutics Description and Business Overview
    Table 117. CRISPR Therapeutics Universal Cell Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. CRISPR Therapeutics Universal Cell Therapy Drug Product
    Table 119. CRISPR Therapeutics Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Universal Cell Therapy Drug Distributors List
    Table 123. Universal Cell Therapy Drug Customers List
    Table 124. Universal Cell Therapy Drug Market Trends
    Table 125. Universal Cell Therapy Drug Market Drivers
    Table 126. Universal Cell Therapy Drug Market Challenges
    Table 127. Universal Cell Therapy Drug Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Universal Cell Therapy Drug
    Figure 2. Global Universal Cell Therapy Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Universal Cell Therapy Drug Market Share by Type in 2023 & 2030
    Figure 4. Cell Therapy Product Picture
    Figure 5. Gene Therapy Product Picture
    Figure 6. Stem Cell Therapy Product Picture
    Figure 7. Global Universal Cell Therapy Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Universal Cell Therapy Drug Market Share by Application in 2023 & 2030
    Figure 9. Hospital
    Figure 10. Research Center
    Figure 11. Global Universal Cell Therapy Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Universal Cell Therapy Drug Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Universal Cell Therapy Drug Sales (2019-2030) & (K Units)
    Figure 14. Global Universal Cell Therapy Drug Average Price (US$/Unit) & (2019-2030)
    Figure 15. Universal Cell Therapy Drug Report Years Considered
    Figure 16. Universal Cell Therapy Drug Sales Share by Manufacturers in 2023
    Figure 17. Global Universal Cell Therapy Drug Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Universal Cell Therapy Drug Players: Market Share by Revenue in 2023
    Figure 19. Universal Cell Therapy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Universal Cell Therapy Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Universal Cell Therapy Drug Sales Market Share by Country (2019-2030)
    Figure 22. North America Universal Cell Therapy Drug Revenue Market Share by Country (2019-2030)
    Figure 23. United States Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Universal Cell Therapy Drug Sales Market Share by Country (2019-2030)
    Figure 26. Europe Universal Cell Therapy Drug Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Universal Cell Therapy Drug Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Universal Cell Therapy Drug Revenue Market Share by Region (2019-2030)
    Figure 34. China Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. China Taiwan Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Southeast Asia Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Latin America Universal Cell Therapy Drug Sales Market Share by Country (2019-2030)
    Figure 42. Latin America Universal Cell Therapy Drug Revenue Market Share by Country (2019-2030)
    Figure 43. Mexico Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Brazil Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Argentina Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Universal Cell Therapy Drug Sales Market Share by Country (2019-2030)
    Figure 47. Middle East & Africa Universal Cell Therapy Drug Revenue Market Share by Country (2019-2030)
    Figure 48. Turkey Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Saudi Arabia Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. UAE Universal Cell Therapy Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Global Sales Market Share of Universal Cell Therapy Drug by Type (2019-2030)
    Figure 52. Global Revenue Market Share of Universal Cell Therapy Drug by Type (2019-2030)
    Figure 53. Global Universal Cell Therapy Drug Price (US$/Unit) by Type (2019-2030)
    Figure 54. Global Sales Market Share of Universal Cell Therapy Drug by Application (2019-2030)
    Figure 55. Global Revenue Market Share of Universal Cell Therapy Drug by Application (2019-2030)
    Figure 56. Global Universal Cell Therapy Drug Price (US$/Unit) by Application (2019-2030)
    Figure 57. Universal Cell Therapy Drug Value Chain
    Figure 58. Universal Cell Therapy Drug Production Process
    Figure 59. Channels of Distribution (Direct Vs Distribution)
    Figure 60. Distributors Profiles
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS